4//SEC Filing
EndoChoice Holdings, Inc. 4
Accession 0001623919-16-000101
CIK 0001623919operating
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 10:22 AM ET
Size
8.4 KB
Accession
0001623919-16-000101
Insider Transaction Report
Form 4
Kaufman David L
Director
Transactions
- Will/Inheritance
Common stock, par value $0.001 per share
2016-06-09+1,500→ 12,587 total - Disposition to Issuer
Common stock, par value $0.001 per share
2016-11-22$8.00/sh−12,587$100,696→ 0 total - Disposition to Issuer
Common stock, par value $0.001 per share
2016-11-22$8.00/sh−2,088,209$16,705,672→ 0 total(indirect: By LLC)
Footnotes (2)
- [F1]Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the "Merger"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer.
- [F2]The reporting person is a Founder and Senior Managing Director of Envest Holdings LLC and as a result may be deemed to beneficially own the shares owned by Envest Holdings or related entities.
Documents
Issuer
EndoChoice Holdings, Inc.
CIK 0001623919
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001623919
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 10:22 AM ET
- Size
- 8.4 KB